Listings
In this section
Events
Excellence Awards
Innovation Rankings
Buyer's Guides
11/18/2024 10:28:16
Home | Cell and gene therapy approvals drive paradigm change in manufacturing
Editor's letter
Contents
Mimotopes Company Insight
Mimotopes
Syngene Company Insight
Syngene
Briefing
News in Numbers
Latest News
Latest Deals
Project Updates
PCI Pharma Services
AlfatestLAB - CPHI
RHEACELL Company Insight
In Depth
Cell and gene therapy approvals drive paradigm change in manufacturing
After the Lykos debacle, what’s next for psychedelic therapies?
Compounding pharmacies caught in counterfeit controversy
How the Covid-19 pandemic will help researchers with the mpox emergency
Iterum’s oral sulopenem acceptance hinges on antibiotic stewardship efforts
Clinical research in the UK must build on industry collaboration, says NIHR director
Keytruda and Opdivo: a decade review
Alphial - CPHI
Rephine
Rephine - CPHI
Thematic Take: AI
Thematic Take: contents
Foreword: Generative AI as a force of creative destruction
The road to advanced AI capabilities
AI technology: Market size and growth forecasts
Timeline: a history of AI
The impact of AI on the pharma sector
Case studies: AI in pharma
Latest news: AI in pharma
AI boom set to revolutionise healthcare in Europe
How NVIDIA grew with the healthcare market instead of pushing into it
Capturing the genAI boom for drug development
New AI model boosts early osteoporosis diagnosis for ageing populations
Impact of AI on metabolic disorder clinical trials
Resist temptation to rapidly roll out AI – executives must focus on talent and training
Is AI really helping employees?
Is your business ready for the rise of AI agents?
Deal activity related to AI in the pharma industry since 2021
Sponsored Supplements
BEA Technologies
Techniconsult Firenze - CPHI
Science4Tech
Listings
Events
Excellence Awards
Innovation Rankings
Buyer's Guides
Next issue
10/07/2024 00:00:00